Skip to content
Recall Observatory FDA recall evidence

Drug product

Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. NDC: 00597-0300-45

D-0657-2026

June 12, 2026

Class II

Product summary

Firm
Boehringer Ingelheim Pharmaceuticals, Inc.
Event
Event 99233
Status
Ongoing
Classification
Class II
Quantity
560 bottles
Official record key
drug-enforcement:D-0657-2026

Official wording

Reason: CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

Code information: Lot 3244413; Exp. 12/31/2028

Distribution pattern: OH

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations